DEUTSCHE BANK AG\ - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 125 filers reported holding SUTRO BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$117,224
-9.8%
33,782
+20.9%
0.00%
Q2 2023$129,893
-14.5%
27,934
-15.0%
0.00%
Q1 2023$151,892
-17.8%
32,877
+43.7%
0.00%
Q4 2022$184,830
+88.6%
22,875
+29.2%
0.00%
Q3 2022$98,000
-9.3%
17,711
-14.2%
0.00%
Q2 2022$108,000
-44.6%
20,654
-13.2%
0.00%
Q1 2022$195,000
-77.1%
23,793
-58.4%
0.00%
Q4 2021$850,000
-19.3%
57,150
+2.5%
0.00%
Q3 2021$1,053,000
+0.2%
55,754
-1.4%
0.00%
-100.0%
Q2 2021$1,051,000
-60.5%
56,554
-51.6%
0.00%0.0%
Q1 2021$2,658,000
+4.7%
116,807
-0.1%
0.00%
-50.0%
Q4 2020$2,538,000
+1674.8%
116,894
+726.0%
0.00%
Q3 2020$143,000
+123.4%
14,152
+72.1%
0.00%
Q2 2020$64,000
+88.2%
8,223
+143.4%
0.00%
Q1 2020$34,000
-58.5%
3,379
-55.3%
0.00%
Q4 2019$82,000
+228.0%
7,559
+164.1%
0.00%
Q3 2019$25,000
-75.0%
2,862
-67.9%
0.00%
Q2 2019$100,000
-4.8%
8,906
-4.7%
0.00%
Q1 2019$105,000
+20.7%
9,349
-4.7%
0.00%
Q4 2018$87,0009,8150.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders